169 related articles for article (PubMed ID: 21115777)
1. Point: Intensive glycemic control and mortality in ACCORD--a chance finding?
Lachin JM
Diabetes Care; 2010 Dec; 33(12):2719-21. PubMed ID: 21115777
[No Abstract] [Full Text] [Related]
2. Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues.
Riddle MC
Diabetes Care; 2010 Dec; 33(12):2722-4. PubMed ID: 21115778
[No Abstract] [Full Text] [Related]
3. Treatment of glycemic control in diabetes in the CVOT era.
Einhorn D
J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
[No Abstract] [Full Text] [Related]
4. [Cardiovascular outcome trials in patients with diabetes].
Mannucci E
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):27S-31S. PubMed ID: 25623548
[TBL] [Abstract][Full Text] [Related]
5. A cardiologist's view of hypoglycemia.
Nandish S; Wyatt J; Oliveros R; Zion AS; Lujan M; Chilton R
Curr Atheroscler Rep; 2010 Mar; 12(2):88-95. PubMed ID: 20425243
[TBL] [Abstract][Full Text] [Related]
6. [Hypoglycemia and cardiovascular risk].
Avogaro A
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
[TBL] [Abstract][Full Text] [Related]
7. Intensive glycemic control and cardiovascular disease: an update.
Brown A; Reynolds LR; Bruemmer D
Nat Rev Cardiol; 2010 Jul; 7(7):369-75. PubMed ID: 20404853
[TBL] [Abstract][Full Text] [Related]
8. Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial.
Shah HS; Gao H; Morieri ML; Skupien J; Marvel S; Paré G; Mannino GC; Buranasupkajorn P; Mendonca C; Hastings T; Marcovina SM; Sigal RJ; Gerstein HC; Wagner MJ; Motsinger-Reif AA; Buse JB; Kraft P; Mychaleckyj JC; Doria A
Diabetes Care; 2016 Nov; 39(11):1915-1924. PubMed ID: 27527847
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
10. The end point is just the beginning.
Muchmore D
J Diabetes Sci Technol; 2011 Sep; 5(5):1287-9. PubMed ID: 22027330
[TBL] [Abstract][Full Text] [Related]
11. Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.
Dhar GC
Can Fam Physician; 2009 Aug; 55(8):803-4. PubMed ID: 19675265
[No Abstract] [Full Text] [Related]
12. [Glycemic control and cardiovascular benefit: what do we know today?].
Egidi G; Popert U
Dtsch Med Wochenschr; 2011 May; 136(19):1027; author reply 1027-8. PubMed ID: 21544796
[No Abstract] [Full Text] [Related]
13. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
Mannucci E; Monami M; Ceriello A; Rotella CM
Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
[No Abstract] [Full Text] [Related]
14. Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia.
Cryer PE
Diabetes; 2014 Jul; 63(7):2188-95. PubMed ID: 24962915
[TBL] [Abstract][Full Text] [Related]
15. Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough?
Triplitt C
Consult Pharm; 2010 Jun; 25 Suppl B():19-27. PubMed ID: 20726379
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
Meier M; Hummel M
Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
[TBL] [Abstract][Full Text] [Related]
17. The International Diabetes Federation’s 2013 World Diabetes Congress, Melbourne, Australia.
J Diabetes; 2014 May; 6(3):197-201. PubMed ID: 24418324
[No Abstract] [Full Text] [Related]
18. The Intersection of Diabetes and Cardiovascular Disease.
Petak S; Sardhu A
Methodist Debakey Cardiovasc J; 2018; 14(4):249-250. PubMed ID: 30788009
[No Abstract] [Full Text] [Related]
19. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
[TBL] [Abstract][Full Text] [Related]
20. Individualizing glycemic targets in type 2 diabetes mellitus.
Aron D; Conlin PR; Hobbs C; Vigersky RA; Pogach L
Ann Intern Med; 2011 Sep; 155(5):340-1. PubMed ID: 21893635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
